Skip to main content
Equibles

CUBT · Curative Biotechnology Inc

Track CUBT — free

Use CUBT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CUBT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.81 +0.00 (+0.00%) At close · Nov 12
Rebalance outlook locked
Market Cap
$7.16M
Shares
8.89M
Volume · Nov 12 534 Avg daily vol (3M) 1109

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.81 Open$0.71 Day$0.71–0.81 52W close$0.65–1.94 Avg vol 30d2K Short int2K · 0.0% of shares · 1.0d Short vol77% DataJan 2020–Nov 2026

Latest documents

2025
2024
2023
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −26%
below
Price vs 50-day avg −9%
below
RSI (14) 48
neutral
MACD trend Positive
52-week position 12%
near low
Momentum
relative strength
Very Weak
1-month return −15%
trailing
6-month return −33%
trailing
YTD return −1%
this year
Relative strength −35%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 16
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 210%
annualized · 1-yr
Max drawdown −66%
past year
ATR 18.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−26% Bearish
Price vs 50-day avg
−9% Bearish
RSI (14)
48 Neutral
MACD trend
Positive Bullish
52-week position
12% Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $1 Now $1 · 12% Range high $2
vs 200-day avg -26% vs 50-day avg -9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CUBT
Curative Biotechnology Inc
this stock
$7.16M — — — 0.0%
VRTX
Vertex Pharmaceuticals Inc
 $137.57B +19.7% +46.2% 34.9 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $98.40B +23.2% +20.8% 21.0 2.1%
MRNA
Moderna, Inc.
 $93.61B +684.5% +4.3% — 8.2%
CSLLY
Csl Ltd
 $66.55B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
2.0K
Days to cover
1.0d
Change
+2.0K sh
View
Short Volume
Short vol %
77%
As of
Nov 11, 2026
Short Total
View
Fails to Deliver
FTD shares
24
Value
$29
As of
Mar 27, 2026
View
Off-Exchange
Off-exchange %
80.5%
Week of
Oct 5, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
S-1/A
Filed
Aug 1, 2025
This year
0
View
Exempt Offerings
Offering
$919.0K
Filed
Jan 18, 2023
View
Earnings & Events
Investor Relations
Latest news
Curative Biotechnology Announces…
Published
Oct 30, 2026
View

Performance

5D 20D 120D MTD YTD
CUBT +15.0% -15.2% -33.2% +23.9% -0.6%
SPY +3.3% -1.9% +1.5% +0.2% +11.0%
vs SPY +11.7% -13.3% -34.8% +23.7% -11.6%
Key facts CIK 1400271 CUSIP 23128N306 Visit website Investor relations